Clinical Significance of Lipoprotein Particles

[1]  J. Fruchart,et al.  Enzyme-linked immunosorbent assay for human proapolipoprotein A-I using specific antibodies against synthetic peptide. , 1988, Journal of lipid research.

[2]  G. Vanhoutte,et al.  Lipoprotein abnormalities in chronic haemodialysis patients. , 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  J. Fruchart,et al.  Effect of fenofibrate treatment on type III hyperlipoproteinemia. , 1987, The American journal of medicine.

[4]  J. Fruchart,et al.  Apolipoprotein A-I containing lipoproteins in coronary artery disease. , 1987, Atherosclerosis.

[5]  J. Fruchart,et al.  A monoclonal antibody (BIP 45) detects Ag(c,g) polymorphism of human apolipoprotein B. , 1987, Journal of immunological methods.

[6]  P. Fiévet,et al.  Detection of human apolipoprotein B polymorphic species with one monoclonal antibody (BIP 45) against low density lipoprotein. Influence of this polymorphism on lipid levels and coronary artery stenosis. , 1987, Atherosclerosis.

[7]  J. Fruchart,et al.  Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. , 1987, Biochemical and biophysical research communications.

[8]  J. Fruchart,et al.  Effect of Fenofibrate on Lipoprotein Particles Predictive of Coronary Atherosclerosis , 1987 .

[9]  C. Demarquilly,et al.  Utilisation d'anticorps polyclonaux et monoclonaux pour le dépistage de l'athérosclérose. Intérêt de nouveaux marqueurs , 1987 .

[10]  J. Fruchart,et al.  Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay. , 1987, Clinical chemistry.

[11]  J. Albers,et al.  Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins. , 1986, Journal of lipid research.

[12]  P. Whitehead,et al.  Drinking and the prevention of coronary heart disease: findings, issues and public health policy. , 1986, Journal of studies on alcohol.

[13]  J. Fruchart,et al.  Synthetic peptides as alternative antigens in the production of antibodies against human apolipoproteins. , 1985, Clinical chemistry.

[14]  B. Pau,et al.  Monoclonal antibodies to low density lipoprotein used for the study of low- and very-low-density lipoproteins, in "ELISA" and immunoprecipitation technics. , 1984, Biochemical and Biophysical Research Communications - BBRC.

[15]  R. Mahley,et al.  Plasma lipoproteins: apolipoprotein structure and function. , 1984, Journal of lipid research.

[16]  G. Miller,et al.  Clinical and metabolic aspects of high-density lipoproteins , 1984 .

[17]  J. Chapelle,et al.  Stepwise probit discrimination with specific application to short-term prognosis in acute myocardial infarction. , 1981, Computers and biomedical research, an international journal.

[18]  L. Lewis,et al.  Lipoproteins : basic principles and concepts , 1980 .

[19]  H. Bergmeyer.  Methods of Enzymatic Analysis , 2019 .